The minimal expression observed in endometrioid adenocarcinoma (scoring 0-1) is noteworthy, as prior studies indicate a downregulation of stromal calretinin in malignant cases, which may be associated with a loss of differentiation and tumor advancement [26]. Here, CALB2 is linked to endometrioid adenocarcinoma.